相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Effects of ketamine treatment on suicidal ideation: a qualitative study of patients' accounts following treatment for depression in a UK ketamine clinic
Karen Lascelles et al.
BMJ OPEN (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study
John Hartberg et al.
PSYCHOPHARMACOLOGY (2018)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug
Agnieszka Palucha-Poniewiera
PHARMACOLOGICAL REPORTS (2018)
The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
Chadi G. Abdallah et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
Cristina Cusin et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series
Maryam I. Al Shirawi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Antidepressants and suicide risk in depression
Philppe Courtet et al.
WORLD PSYCHIATRY (2017)
Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
Rebecca B. Price et al.
DEPRESSION AND ANXIETY (2014)
Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
Elizabeth D. Ballard et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
GluN2B-Containing NMDA Receptors Regulate Depression-Like Behavior and are Critical for the Rapid Antidepressant Actions of Ketamine
Oliver H. Miller et al.
ELIFE (2014)
The Suicidal Ideation Attributes Scale (SIDAS): Community-Based Validation Study of a New Scale for the Measurement of Suicidal Ideation
Bregje A. J. van Spijker et al.
SUICIDE AND LIFE-THREATENING BEHAVIOR (2014)
Ketamine as a new treatment for depression: A review of its efficacy and adverse effects
Natalie Katalinic et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Biological basis of suicide and suicidal behavior
Ghanshyam N. Pandey
BIPOLAR DISORDERS (2013)
Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression
J. J. Mann et al.
EUROPEAN PSYCHIATRY (2010)
Acute stress reaction and completed suicide
Jaimie L. Gradus et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Psychiatric diagnoses in 3275 suicides: a meta-analysis
Genevieve Arsenault-Lapierre et al.
BMC PSYCHIATRY (2004)
Chronic suicidality among patients with borderline personality disorder
J Paris
PSYCHIATRIC SERVICES (2002)
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
JH Krystal et al.
MOLECULAR PSYCHIATRY (2002)